The Translational Educator

Listening to Dr. Victoria Werth lecture in dermatology is like taking a master class —one where you hang onto every word and commit to developing your career with as high a degree of intention as she has.

A Practice of Care

Dr. William Sawchuk first learned about dermatology when he was a boy and his brother needed treatment for a severe case of acne. The family met with the local dermatologist, a hardship for a blue-collar family, who provided the necessary treatment.

Serving the Underserved, Encouraging the Underrepresented

Hidradenitis suppurativa (HS) was a skin disease Dr. Ginette Okoye had never given much thought to before she entered her first faculty appointment.

Climate Change and Dermatology

Dr. Davis presented on climate change and dermatology. He spoke about climate change definitions, consequences, effects on the skin, effects on dermatology, and what dermatologists can do individually and as a group to address climate change.

When to Suspect Immunodeficiency

Dr. Treat presented three types of clinical scenarios suggesting immunodeficiency: primary skin findings of infections that are unusual, opportunistic, or exuberant; secondary skin findings of eczematous or granulomatous changes; and immunosuppressed groups.

The Curious Syndrome of Erythromelalgia

Dr. Davis presented his medical experiences of patients with erythromelalgia. He typically sees 3-5 new patients with erythromelalgia per week.

New Insights from Genetic Analysis of Cutaneous Adnexal Tumors

Dr. North presented new insights from genetic analysis of cutaneous adnexal tumors.

Clues for Diagnosing Uncommon Inflammatory Diseases

Dr. North presented cases of uncommon inflammatory skin diseases and the clues for diagnosis.

Pediatric Connective Tissue Disease: Cases that Taught Me a Lesson

Dr. Chiu presented 4 cases of pediatric connective tissue diseases and the lessons learned from each case.

New Topical Therapies for Psoriasis and Atopic Dermatitis

Dr. Bhutani presented new topical therapies for psoriasis and atopic dermatitis, including tapinarof, roflumilast, and ruxolitinib.